- Home
- MASK vs GDTC Comparison
MASK vs GDTC Comparison
Compare MASK & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASK
- GDTC
- Stock Information
- Founded
- MASK 2017
- GDTC 2018
- Country
- MASK China
- GDTC Singapore
- Employees
- MASK N/A
- GDTC N/A
- Industry
- MASK
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- MASK
- GDTC Health Care
- Exchange
- MASK NYSE
- GDTC Nasdaq
- Market Cap
- MASK 31.7M
- GDTC 29.4M
- IPO Year
- MASK 2025
- GDTC 2023
- Fundamental
- Price
- MASK $2.77
- GDTC $2.56
- Analyst Decision
- MASK
- GDTC Buy
- Analyst Count
- MASK 0
- GDTC 1
- Target Price
- MASK N/A
- GDTC $5.00
- AVG Volume (30 Days)
- MASK 92.1K
- GDTC 20.3K
- Earning Date
- MASK 01-01-0001
- GDTC 01-01-0001
- Dividend Yield
- MASK N/A
- GDTC N/A
- EPS Growth
- MASK 55.43
- GDTC N/A
- EPS
- MASK 0.15
- GDTC N/A
- Revenue
- MASK $4,561,963.00
- GDTC $330,254.00
- Revenue This Year
- MASK N/A
- GDTC $14.71
- Revenue Next Year
- MASK N/A
- GDTC N/A
- P/E Ratio
- MASK $17.89
- GDTC N/A
- Revenue Growth
- MASK 172.95
- GDTC N/A
- 52 Week Low
- MASK $2.50
- GDTC $1.20
- 52 Week High
- MASK $3.99
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- MASK N/A
- GDTC 46.58
- Support Level
- MASK N/A
- GDTC $2.46
- Resistance Level
- MASK N/A
- GDTC $2.94
- Average True Range (ATR)
- MASK 0.00
- GDTC 0.21
- MACD
- MASK 0.00
- GDTC -0.01
- Stochastic Oscillator
- MASK 0.00
- GDTC 38.71
About MASK 3 E NETWORK TECHNOLOGY GROUP LTD
3 E Network Technology Group Ltd is a business-to-business ("B2B") information technology ("IT") business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.